2142 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
HBM Holdings Ltd. is an investment company, which engages in the discovery and development of differentiated antibody therapeutics in oncology and immunology disease areas. It operates through the following geographical segments: Europe, Mainland China, United States, and Others. The company was founded by Xiao Xiang Chen, Qi He, Schweizer Liang, Mai Jing Liao, Xiao Xi Liu, and Jing Song Wang on July 20, 2016 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
2142 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company